Can we afford to pay for future cures?
Pharmaceutical R&D is racing ahead of our health system's ability to adjust payment models, but innovative concepts are finally emerging.
top of page
Vocal.
Search
Ulrich Neumann, MBA MSc MA
- Nov 14, 2019
- 6 min
Prescription Drug Pricing: “The Times They Are A Changin”
The drug pricing debate in DC has intensified, and the pharmaceutical industry has become the prime target of bipartisan outrage.
Ulrich Neumann, MBA MSc MA
- Oct 9, 2019
- 10 min
'ICER' strikes again - Scandal time?
The drug-price watchdog ICER just issued a "Report on Unsupported Price Increases". The 'study' made the headlines, but it is problematic.
Ulrich Neumann, MBA MSc MA
- May 31, 2019
- 5 min
Real World Evidence: From Market Access to Drug Approval
This analysis outlines recent developments in the use of real-world evidence (RWE) and the sizeable impact it stands to make the industry.
Directly blog
bottom of page